For the Quarter Ending March 2026
Doxepin Hydrochloride Prices in North America
- In United States, the Doxepin Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by surging precursor costs.
- The Doxepin Hydrochloride Production Cost Trend increased as the Producer Price Index rose 4.0% in March 2026.
- Consumer Price Index inflation of 3.3% in March 2026 elevated transportation expenses for Doxepin Hydrochloride supply chains.
- The Doxepin Hydrochloride Demand Outlook strengthened, supported by resilient retail sales growth of 4.0% in March 2026.
- A 4.3% unemployment rate and 91.8 consumer confidence in March 2026 sustained Doxepin Hydrochloride prescription access.
- Industrial production grew 0.7% in March 2026, preventing oversupply in the domestic Doxepin Hydrochloride market.
- The Manufacturing Index expanded in March 2026, ensuring steady packaging availability for Doxepin Hydrochloride formulations.
- Global naphtha and benzene feedstock costs spiked in March 2026, elevating Doxepin Hydrochloride manufacturing expenses.
- The Doxepin Hydrochloride Price Forecast indicated upward momentum in Q1 2026 as pharmaceutical producer prices strengthened.
Why did the price of Doxepin Hydrochloride change in March 2026 in North America?
- Surging global naphtha and benzene costs in March 2026 directly elevated Doxepin Hydrochloride production expenses.
- Middle East export disruptions in March 2026 severely restricted the availability of critical chemical precursors.
- Resilient retail sales and stable pharmaceutical shipments in February 2026 maintained strong baseline market demand.
Doxepin Hydrochloride Prices in APAC
- In China, the Doxepin Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream petrochemical costs.
- The Doxepin Hydrochloride Production Cost Trend increased in March 2026 as the PPI grew by 0.5%.
- The Doxepin Hydrochloride Demand Outlook remained stable in March 2026, supported by a 1.0% CPI increase.
- Industrial production grew by 5.7% in March 2026, ensuring ample Doxepin Hydrochloride supply for downstream formulation.
- Retail sales grew slowly by 1.7% in March 2026, reflecting softer consumer spending on discretionary pharmacy items.
- The urban unemployment rate reached 5.4% in March 2026, historically correlating with increased stress-related psychiatric prescriptions.
- Consumer confidence stood at 91.6 in February 2026, indicating cautious household spending on non-emergency healthcare treatments.
- The Manufacturing Index expanded in March 2026, reflecting robust production capabilities for pharmaceutical and fine chemical sectors.
- The Doxepin Hydrochloride Price Forecast trended upward in Q1 2026 as upstream naphtha feedstock costs rose sharply.
Why did the price of Doxepin Hydrochloride change in March 2026 in APAC?
- Upstream petrochemical and naphtha feedstock costs surged in Q1 2026 due to Middle East supply chain disruptions.
- Chinese chemical export volumes surged in March 2026, tightening domestic availability and driving up market valuations.
- Inquiries for phenol, a key feedstock, increased in Q1 2026 as regional production plants reduced operating capacity.
Doxepin Hydrochloride Prices in Europe
- In Germany, the Doxepin Hydrochloride Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- Higher inflation at 2.7% in March 2026 increased operational costs, elevating the Doxepin Hydrochloride production cost trend.
- Producer prices declined by -0.2% in March 2026, indicating slightly eased upstream chemical precursor expenses.
- The Manufacturing Index expanded in March 2026, tightening the supply of shared industrial inputs for pharmaceutical packaging.
- Stagnant industrial production at 0.0% in February 2026 reflected flat baseline availability for bulk API synthesis capacity.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, sustaining the Doxepin Hydrochloride demand outlook.
- Negative consumer confidence at -24.7 in March 2026 caused cautious household spending, impacting outpatient psychiatric treatment applications.
- Pharmaceutical formulation demand strengthened across Europe in Q1 2026, supporting a firm Doxepin Hydrochloride price forecast.
Why did the price of Doxepin Hydrochloride change in March 2026 in Europe?
- Phenol feedstock costs for Doxepin Hydrochloride synthesis surged in Q1 2026 due to elevated electricity expenses.
- Phthalic anhydride feedstock costs spiked in March 2026 following surging upstream orthoxylene and mixed xylenes prices.
- Regional phenol feedstock supply tightened in Q1 2026 following major industry outages and permanent facility closures.
For the Quarter Ending December 2025
Doxepin Hydrochloride Prices in North America
- In the United States, the Doxepin Hydrochloride Price Index rose quarter-over-quarter in Q4 2025, influenced by rising input costs and robust demand.
- Doxepin Hydrochloride production costs increased, driven by a 3.0% year-over-year rise in PPI in November 2025.
- Demand for Doxepin Hydrochloride was supported by a 3.3% year-over-year increase in retail sales in November 2025.
- A 2.7% year-over-year CPI increase in December 2025 indicated general inflation, raising raw material and energy costs.
- US Active Pharmaceutical Ingredients market expanded in 2025, bolstering Doxepin Hydrochloride demand.
- Industrial production increased 2.0% year-over-year in December 2025, supporting Doxepin Hydrochloride supply chain stability.
- Natural gas spot prices moved upward in late 2025 due to a December cold snap.
- Trade flows faced continuous change in 2025 due to geopolitical uncertainty and potential trade disputes.
- A 4.4% unemployment rate in December 2025 supported Doxepin Hydrochloride demand through increased healthcare access.
Why did the price of Doxepin Hydrochloride change in December 2025 in North America?
- Rising input costs, evidenced by a 3.0% PPI increase in November 2025, pressured Doxepin Hydrochloride prices.
- Strong consumer spending, with retail sales up 3.3% in November 2025, supported Doxepin Hydrochloride demand.
- Increased general inflation, shown by a 2.7% CPI rise in December 2025, contributed to higher production costs.
Doxepin Hydrochloride Prices in APAC
- In China, the Doxepin Hydrochloride Price Index fell quarter-over-quarter in Q4 2025, influenced by declining production costs and weak demand.
- Doxepin Hydrochloride production costs decreased in Q4 2025, as the Producer Price Index declined by 1.9% in December 2025.
- Aromatic hydrocarbon (benzene) and propylene feedstock costs faced bearish pressure in Q4 2025 due to oversupply.
- Doxepin Hydrochloride demand was constrained by weak consumer spending, with retail sales growing 0.9% in December 2025.
- China's Manufacturing Index expanded in December 2025, supporting stable supply chains for Doxepin Hydrochloride.
- Industrial Production grew by 5.2% in December 2025, indicating robust manufacturing activity for intermediate chemicals.
- The pharmaceutical industry in China experienced robust growth throughout 2025, propelled by an aging population.
- Europe-origin benzene cargoes emerged in Asia during November-December 2025, indicating surplus volumes.
Why did the price of Doxepin Hydrochloride change in December 2025 in APAC?
- Producer Price Index declined by 1.9% in December 2025, reducing manufacturing costs for Doxepin Hydrochloride.
- Aromatic hydrocarbon (benzene) and propylene feedstock costs faced bearish pressure in Q4 2025 due to oversupply.
- Weak consumer demand, with retail sales growing 0.9% in December 2025, impacted overall healthcare spending.
Doxepin Hydrochloride Prices in Europe
- In Germany, the Doxepin Hydrochloride Price Index experienced downward pressure in Q4 2025, influenced by declining producer prices.
- Doxepin Hydrochloride production costs faced persistent high energy and raw material costs throughout 2025.
- The Manufacturing Index contracted in December 2025, indicating a broader economic slowdown.
- Consumer confidence declined significantly to -17.5 in December 2025, reflecting widespread economic pessimism.
- The Doxepin Hydrochloride Price Index was influenced by a -2.5% PPI decrease in December 2025.
- Moderate inflation, with CPI at 1.8% in December 2025, contributed to increased Doxepin Hydrochloride operational costs.
- Industrial production grew by 0.8% in October 2025, supporting stable supply chains for Doxepin Hydrochloride.
- Retail sales increased by 1.1% in November 2025, indirectly supporting healthcare funding and access.
- A stable unemployment rate of 6.2% in December 2025 supported health insurance coverage for Doxepin Hydrochloride.
- Pharmaceutical industry growth increased in December 2025, supporting Doxepin Hydrochloride market stability.
Why did the price of Doxepin Hydrochloride change in December 2025 in Europe?
- Producer prices decreased by 2.5% in December 2025, reducing Doxepin Hydrochloride manufacturing input costs.
- Persistent high energy and raw material costs in 2025 maintained upward pressure on production.
- Increased German pharmaceutical output in December 2025 supported Doxepin Hydrochloride demand.
For the Quarter Ending September 2025
Doxepin Hydrochloride Prices in North America
- In the United States, the Doxepin Hydrochloride Price Index rose quarter-over-quarter in Q3 2025, driven by escalating production costs.
- Production costs increased due to a 2.6% PPI rise in August 2025 and higher Q3 2025 energy prices.
- Demand for Doxepin Hydrochloride was supported by strengthened US pharmaceutical market sentiment in Q3 2025.
- A 4.3% unemployment rate and 5.42% retail sales growth in September 2025 bolstered Doxepin Hydrochloride demand.
- Overall chemical demand weakened in Q3 2025, with new chemical orders declining, impacting broader supply.
- US tariffs on pharmaceutical imports and APIs contributed to inflationary effects on drug production costs in 2025.
- Chemical industry inventories shrank in Q3 2025 due to accelerating destocking, tightening supply.
- The Doxepin Hydrochloride price forecast indicates continued upward pressure from sustained input cost increases.
Why did the price of Doxepin Hydrochloride change in September 2025 in North America?
- Production costs rose from a 3.0% CPI increase in September 2025 and higher U.S. natural gas prices.
- Demand was supported by a low 4.3% unemployment rate in September 2025, increasing healthcare access.
- US tariffs on pharmaceutical imports in 2025 created inflationary effects on drug production expenses.
Doxepin Hydrochloride Prices in APAC
- In China, the Doxepin Hydrochloride Price Index fell quarter-over-quarter in Q3 2025, influenced by declining production costs and overcapacity.
- Doxepin Hydrochloride production costs decreased in Q3 2025, driven by a 2.3% year-on-year fall in PPI and lower feedstock costs.
- Doxepin Hydrochloride demand outlook remains stable, supported by a 3.0% year-on-year rise in retail sales in September 2025.
- Pharmaceutical market demand strengthened in Q3 2025, driven by an aging population and chronic diseases.
- Overall chemical industry demand weakened in Q3 2025, with manufacturing activity contracting in September 2025.
- Persistent chemical industry overcapacity in China during Q3 2025 intensified market competition.
- High inventories of 1,4-Butanediol in July 2025 created downward price pressure for related chemicals.
- The Doxepin Hydrochloride Price Index forecast suggests continued pressure due to ample supply and weak overall chemical demand.
Why did the price of Doxepin Hydrochloride change in September 2025 in APAC?
- Falling raw material costs, with PPI down 2.3% year-on-year in September 2025, reduced production expenses.
- Persistent chemical industry overcapacity in China during Q3 2025 intensified market competition.
- Weakening overall chemical industry demand in Q3 2025 impacted Doxepin Hydrochloride pricing.
Doxepin Hydrochloride Prices in Europe
- In Germany, the Doxepin Hydrochloride Price Index remained stable quarter-over-quarter in Q3 2025, influenced by softening producer prices.
- Doxepin Hydrochloride production costs saw mixed trends in Q3 2025, with producer prices declining 1.7% year-over-year in September 2025.
- Raw material costs for the German chemical industry remained elevated during Q3 2025, with CPI at 2.4% year-over-year in September 2025.
- Demand for Doxepin Hydrochloride was supported by an expanding pharmaceutical market and low 3.9% unemployment in September 2025.
- Low consumer confidence, at -23.6 index in September 2025, presented a bearish outlook for Doxepin Hydrochloride demand.
- Germany's Manufacturing Index contracted in September 2025, indicating a slowdown in overall industrial activity.
- Industrial production in Germany declined by 1.0% year-over-year in September 2025, affecting Doxepin Hydrochloride supply.
- Natural gas prices eased in Germany during Q3 2025, offering some relief to Doxepin Hydrochloride production costs.
Why did the price of Doxepin Hydrochloride change in September 2025 in Europe?
- Producer prices declined 1.7% year-over-year in September 2025, reducing Doxepin Hydrochloride manufacturing input costs.
- Germany's Manufacturing Index contracted in September 2025, signaling supply chain inefficiencies and higher costs.
- Low consumer confidence (-23.6 index in September 2025) tempered Doxepin Hydrochloride demand despite market expansion.
For the Quarter Ending December 2022
North America
The prices of Doxepin Hydrochloride in North America increased moderately over the first part of the fourth quarter. Consistent end-user demand from the pharmaceutical sector kept the prices of Doxepin Hydrochloride on the higher side.
Furthermore, Supply chain disruption decreased rapidly over the six months to November across multiple measures, which did not affect the market sentiments of Doxepin Hydrochloride prices as the inventories with market participants were enough to meet any immediate order.
Until November, the prices of Doxepin Hydrochloride remained on North side and were recorded at USD 168500/MT CFR Los Angeles, but then it began to collapse as December approaches owing to significant drop in its offtakes and New year holidays which results in temporary shutdown of market within the region.
APAC
In the Asia Pacific region, specifically in China, Doxepin Hydrochloride prices plummet during the fourth quarter of 2022. As per the trend, during the first half of q4, the prices inclined positively due to healthy downstream demand balanced with sufficient supplies among the market players. However, the ease in supply chain disruption and port congestion during November compared to October helped the traders and suppliers get more orders and balance the demand side. With the end of the year 2022, China's manufacturing activities began to decrease noticeably after November with a surge in COVID-19 cases. Moreover, the decrease in freight charges positively supported the price trend of Doxepin Hydrochloride. Overall, the price of Doxepin Hydrochloride noted in the mid of the fourth quarter was assembled at USD 150250 /MT FOB Shaanxi.
Europe
In the fourth quarter of 2022, the European market for Doxepin Hydrochloride followed a mixed pattern. The market trend started on a weak note up to November as the demand from the end-user sector pharmaceutical industry remained low. Following November, the prices of Doxepin Hydrochloride witnesses were assembled at USD 171190/MT CFR Hamburg in Germany. Furthermore, inquiries from the downstream sector for Doxepin Hydrochloride prices began to increase moderately in November, keeping the prices on the higher side. Towards the end of the year 2022, fresher orders declined in December due to suppliers having large stock levels due to the market's brief closure.
